Header Logo

Philip Comp

Concepts (399)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Venous Thrombosis
11
2012
98
1.340
Why?
Glycoproteins
23
2003
122
1.180
Why?
Protein C
25
2015
38
1.050
Why?
Warfarin
13
2005
94
0.790
Why?
Thromboembolism
7
2007
57
0.780
Why?
Anticoagulants
16
2008
294
0.750
Why?
Thrombophlebitis
9
2006
51
0.610
Why?
Contraceptives, Oral
6
2006
23
0.550
Why?
Thrombosis
14
2002
149
0.490
Why?
Postoperative Complications
6
2005
611
0.490
Why?
Factor VIIa
5
2006
29
0.470
Why?
Blood Coagulation Factors
7
2006
31
0.460
Why?
Protein S
18
2001
26
0.460
Why?
Receptors, Cell Surface
9
2003
113
0.440
Why?
Prothrombin
5
2006
15
0.430
Why?
Arthroplasty, Replacement, Knee
5
2008
38
0.410
Why?
Fibrinolytic Agents
4
2005
70
0.400
Why?
Blood Coagulation
13
1995
118
0.400
Why?
Protein C Deficiency
7
2002
7
0.400
Why?
Arthroplasty, Replacement, Hip
3
2005
29
0.390
Why?
Humans
77
2017
27968
0.370
Why?
Glycogen Storage Disease Type VII
1
2011
2
0.370
Why?
Mesenteric Veins
1
2011
3
0.370
Why?
Portal Vein
1
2011
8
0.370
Why?
Blood Platelets
7
1998
205
0.360
Why?
Blood Coagulation Tests
6
2006
27
0.350
Why?
Coronary Disease
4
2001
119
0.320
Why?
Thrombomodulin
3
2005
10
0.310
Why?
Point Mutation
2
2006
60
0.300
Why?
Risk Factors
13
2008
2078
0.280
Why?
Nucleic Acid Denaturation
1
2006
4
0.270
Why?
Middle Aged
31
2017
7111
0.260
Why?
Enoxaparin
2
2008
37
0.250
Why?
Female
39
2015
15074
0.250
Why?
Temperature
1
2006
213
0.250
Why?
Genetic Variation
2
2006
241
0.240
Why?
Male
34
2017
13424
0.230
Why?
Coronary Artery Disease
2
1997
216
0.220
Why?
Adult
24
2012
7703
0.220
Why?
Complement Inactivator Proteins
3
1990
8
0.220
Why?
Thrombin
10
2008
69
0.220
Why?
Fibrinogen
6
1996
50
0.210
Why?
Orthopedic Procedures
1
2003
27
0.210
Why?
Aged
23
2015
5383
0.210
Why?
Antibodies, Monoclonal
5
2012
329
0.200
Why?
Factor Xa Inhibitors
1
2003
54
0.200
Why?
Heparin
7
2003
110
0.200
Why?
Thromboplastin
4
2006
28
0.190
Why?
Factor V
7
2006
14
0.180
Why?
Skin
2
1993
147
0.170
Why?
Disseminated Intravascular Coagulation
4
2004
16
0.170
Why?
Venous Thromboembolism
2
2015
133
0.170
Why?
Prospective Studies
8
2015
1244
0.170
Why?
Coronary Angiography
2
1997
150
0.160
Why?
Blood Coagulation Disorders
4
2004
26
0.150
Why?
Embolism
2
1999
14
0.150
Why?
Dermatan Sulfate
1
1998
3
0.150
Why?
Heparitin Sulfate
1
1998
14
0.150
Why?
Platelet Function Tests
2
1998
24
0.150
Why?
Liver Diseases
3
1988
52
0.150
Why?
Chondroitin Sulfates
1
1998
23
0.150
Why?
Neoplasms
3
2017
803
0.150
Why?
Aspirin
3
1998
124
0.150
Why?
Fibrinolysis
7
2004
21
0.140
Why?
Blood Loss, Surgical
2
1998
53
0.130
Why?
Laboratories
1
1996
18
0.130
Why?
Specimen Handling
1
1996
31
0.130
Why?
Protein S Deficiency
3
2006
5
0.130
Why?
Factor VIII
2
2015
19
0.130
Why?
Pregnancy
6
1997
1180
0.130
Why?
Prothrombin Time
3
2006
21
0.120
Why?
Factor VII
3
2006
3
0.120
Why?
Endothelium, Vascular
3
2003
325
0.120
Why?
Disease Progression
1
2017
472
0.120
Why?
Polysaccharides
2
2007
61
0.120
Why?
Azetidines
2
2005
6
0.120
Why?
Ventricular Dysfunction
1
1994
6
0.120
Why?
Aged, 80 and over
8
2012
2015
0.110
Why?
Fibrin Fibrinogen Degradation Products
2
2012
10
0.110
Why?
Double-Blind Method
6
2008
414
0.110
Why?
Thrombolytic Therapy
1
1994
39
0.110
Why?
Antithrombin III Deficiency
3
1992
6
0.110
Why?
Lymphopoiesis
2
2005
22
0.110
Why?
Recombinant Proteins
5
2005
412
0.110
Why?
Contraceptives, Oral, Hormonal
1
1993
9
0.110
Why?
Carrier Proteins
3
1990
252
0.110
Why?
Contraception
1
1993
21
0.110
Why?
Hemostasis
3
1998
48
0.110
Why?
Coumarins
1
1993
5
0.100
Why?
Drug Eruptions
1
1993
7
0.100
Why?
Lymphocytes
2
2005
90
0.100
Why?
Receptors, Thrombin
7
1991
9
0.100
Why?
Positron-Emission Tomography
1
2012
99
0.090
Why?
Cyclosporins
1
1991
2
0.090
Why?
Image Interpretation, Computer-Assisted
1
2012
107
0.090
Why?
Protein Deficiency
1
1990
4
0.090
Why?
Treatment Outcome
7
2007
2367
0.090
Why?
Antithrombin III
2
1992
6
0.090
Why?
Abdomen
2
2007
41
0.090
Why?
Blood Proteins
4
1986
68
0.080
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2006
327
0.080
Why?
Surgical Procedures, Operative
2
2007
50
0.080
Why?
Lupus Coagulation Inhibitor
2
2000
11
0.080
Why?
Animals
16
2005
10370
0.080
Why?
Administration, Oral
3
2008
188
0.080
Why?
Pedigree
6
1991
155
0.080
Why?
Tomography, X-Ray Computed
1
2011
473
0.070
Why?
Benzimidazoles
1
2008
32
0.070
Why?
Logistic Models
3
2001
407
0.070
Why?
Intermittent Pneumatic Compression Devices
1
2007
1
0.070
Why?
Pyridines
1
2008
106
0.070
Why?
Anti-Inflammatory Agents
2
2005
126
0.070
Why?
Radial Artery
1
2007
21
0.070
Why?
DNA Probes
1
2006
13
0.070
Why?
Nucleic Acid Hybridization
1
2006
76
0.070
Why?
Heterozygote
1
2006
65
0.070
Why?
Metabolic Syndrome
1
2007
78
0.060
Why?
Activated Protein C Resistance
1
2006
2
0.060
Why?
Cattle
5
1991
388
0.060
Why?
Pulmonary Embolism
3
2005
126
0.060
Why?
Sequence Analysis, DNA
1
2006
369
0.060
Why?
Immunoelectrophoresis, Two-Dimensional
3
1990
3
0.060
Why?
Pilot Projects
3
1995
430
0.060
Why?
Dexamethasone
1
2005
63
0.060
Why?
Factor X
5
2006
11
0.060
Why?
Cohort Studies
2
2012
884
0.060
Why?
Glucocorticoids
1
2005
115
0.060
Why?
Extracorporeal Circulation
2
1995
3
0.060
Why?
Hypercholesterolemia
2
1995
18
0.060
Why?
Clinical Trials as Topic
2
1996
214
0.060
Why?
Cholesterol, LDL
2
1995
64
0.060
Why?
gamma-Tocopherol
1
2004
1
0.060
Why?
Stem Cells
1
2005
121
0.050
Why?
Antithrombins
1
1984
28
0.050
Why?
Endothelins
1
2003
7
0.050
Why?
Chromans
1
2004
59
0.050
Why?
Postphlebitic Syndrome
1
2003
1
0.050
Why?
Surgical Wound Infection
1
2004
105
0.050
Why?
Sepsis
1
2004
84
0.050
Why?
Heparin, Low-Molecular-Weight
1
2003
35
0.050
Why?
Immunosorbent Techniques
4
1988
12
0.050
Why?
Infusions, Intravenous
1
2003
102
0.050
Why?
Recurrence
3
1992
321
0.050
Why?
Thrombophilia
1
2002
10
0.050
Why?
Genetic Predisposition to Disease
1
1986
665
0.050
Why?
Acute Disease
1
2003
155
0.050
Why?
Phosphodiesterase Inhibitors
1
2002
12
0.050
Why?
Tetrazoles
1
2002
8
0.050
Why?
Patient Education as Topic
1
2003
91
0.050
Why?
Age Factors
3
2002
733
0.050
Why?
Partial Thromboplastin Time
2
2004
18
0.050
Why?
Mutation
1
2006
843
0.050
Why?
Severe Combined Immunodeficiency
1
2001
2
0.050
Why?
Vasodilator Agents
1
2002
79
0.050
Why?
Bleeding Time
3
1998
3
0.050
Why?
Receptors, Estrogen
1
2001
43
0.050
Why?
Hematopoiesis
1
2001
25
0.050
Why?
Necrosis
2
1993
83
0.050
Why?
Helminth Proteins
1
2001
15
0.050
Why?
B-Lymphocyte Subsets
1
2001
30
0.050
Why?
Protein C Inhibitor
3
1986
5
0.050
Why?
Immunoglobulin Fab Fragments
2
2012
21
0.050
Why?
Practice Guidelines as Topic
1
2002
242
0.040
Why?
Postoperative Period
1
2001
67
0.040
Why?
Platelet Aggregation Inhibitors
2
1994
191
0.040
Why?
Immunoassay
1
2001
36
0.040
Why?
Enzyme-Linked Immunosorbent Assay
3
2005
256
0.040
Why?
Time Factors
6
2005
1590
0.040
Why?
Hematopoietic Stem Cell Transplantation
1
2001
80
0.040
Why?
Intermittent Claudication
1
2002
117
0.040
Why?
Smoking
2
1996
473
0.040
Why?
Biomarkers
1
2004
756
0.040
Why?
B-Lymphocytes
1
2002
282
0.040
Why?
Popliteal Vein
1
2000
3
0.040
Why?
Sensitivity and Specificity
3
2012
520
0.040
Why?
Femoral Vein
1
2000
13
0.040
Why?
Analysis of Variance
1
2001
391
0.040
Why?
Diabetes Mellitus, Type 1
1
2001
123
0.040
Why?
Lipids
1
2001
207
0.040
Why?
Dose-Response Relationship, Drug
3
2008
604
0.040
Why?
Aortic Diseases
1
1999
16
0.040
Why?
Iliac Artery
1
1999
19
0.040
Why?
Enzyme Activation
3
1986
267
0.040
Why?
Antibodies
1
2000
124
0.040
Why?
Longitudinal Studies
1
2001
414
0.040
Why?
Hyperhomocysteinemia
1
1999
28
0.040
Why?
Streptokinase
1
1979
5
0.040
Why?
Arterial Occlusive Diseases
1
1999
44
0.040
Why?
Incidence
1
2001
562
0.040
Why?
Femoral Artery
1
1999
58
0.040
Why?
Antibodies, Antiphospholipid
1
1999
27
0.040
Why?
Plasminogen Activators
3
1984
7
0.040
Why?
Cell Lineage
3
2005
51
0.040
Why?
Estrogen Replacement Therapy
1
1999
42
0.040
Why?
Single-Blind Method
1
1998
44
0.040
Why?
Platelet Activation
2
2015
54
0.040
Why?
Radioimmunoassay
2
1990
45
0.040
Why?
Drug Combinations
1
1998
50
0.040
Why?
Platelet Aggregation
3
1998
44
0.040
Why?
Proportional Hazards Models
2
2015
225
0.040
Why?
Blood Platelet Disorders
1
1998
10
0.040
Why?
Phlebography
3
2005
20
0.040
Why?
Drug Therapy, Combination
2
1995
207
0.040
Why?
Diabetes Mellitus
2
1996
215
0.040
Why?
Hemorrhage
3
2005
265
0.030
Why?
Protein Binding
3
1996
657
0.030
Why?
Immunoelectrophoresis
2
1987
3
0.030
Why?
Patient Care Planning
1
1996
24
0.030
Why?
Imaging, Three-Dimensional
1
2017
129
0.030
Why?
Reference Values
2
1987
199
0.030
Why?
Complement C4
2
1986
16
0.030
Why?
Chi-Square Distribution
1
1996
145
0.030
Why?
Placebos
2
2007
47
0.030
Why?
Kinetics
2
1991
544
0.030
Why?
Thrombopoietin
1
1996
17
0.030
Why?
Cells, Cultured
2
2005
984
0.030
Why?
Blood Component Removal
1
1995
4
0.030
Why?
Dogs
3
1996
509
0.030
Why?
Injections, Subcutaneous
2
2008
60
0.030
Why?
Vitamin K
2
1986
39
0.030
Why?
Cardiovascular Diseases
2
2004
364
0.030
Why?
Mice
5
2005
4621
0.030
Why?
Lipoproteins, LDL
1
1995
36
0.030
Why?
Europe
2
2008
98
0.030
Why?
Phosphatidylethanolamines
1
1995
26
0.030
Why?
Benzylamines
2
2005
19
0.030
Why?
Adolescent
4
1998
3104
0.030
Why?
Phospholipids
1
1995
76
0.030
Why?
Heart Aneurysm
1
1994
10
0.030
Why?
Drug Administration Schedule
3
2003
223
0.030
Why?
Sex Factors
1
1996
465
0.030
Why?
ROC Curve
1
1995
143
0.030
Why?
Heart Neoplasms
1
1994
16
0.030
Why?
Cardiomyopathy, Dilated
1
1994
19
0.030
Why?
Interleukin-6
1
1996
192
0.030
Why?
Case-Control Studies
1
1996
719
0.030
Why?
Reproducibility of Results
2
2012
769
0.030
Why?
Fetal Blood
3
2002
38
0.030
Why?
Factor Xa
2
1984
14
0.030
Why?
Bone Marrow Cells
2
2005
80
0.030
Why?
Mice, Inbred NOD
2
2005
49
0.030
Why?
Antigens, CD
2
2005
139
0.030
Why?
Plasmapheresis
1
1993
6
0.030
Why?
Autoanalysis
1
1993
1
0.030
Why?
Infant, Newborn
2
1987
867
0.030
Why?
Plasminogen
2
1986
8
0.030
Why?
Pregnancy Complications, Cardiovascular
1
1992
15
0.020
Why?
Isotope Labeling
1
2012
30
0.020
Why?
Skin Transplantation
1
1992
14
0.020
Why?
Mice, SCID
2
2002
60
0.020
Why?
Transplantation, Heterologous
2
2002
60
0.020
Why?
Sex Characteristics
1
1993
172
0.020
Why?
Radiopharmaceuticals
1
2012
71
0.020
Why?
Autoantibodies
1
1995
474
0.020
Why?
Isoflurophate
2
1982
2
0.020
Why?
Myocardial Infarction
1
1994
345
0.020
Why?
Hypobetalipoproteinemias
1
1991
2
0.020
Why?
Afibrinogenemia
1
1991
3
0.020
Why?
Swine
1
1992
236
0.020
Why?
Cell Differentiation
2
2005
406
0.020
Why?
Chromosome Deletion
1
1991
14
0.020
Why?
Exons
1
1991
42
0.020
Why?
Renal Artery
1
1991
15
0.020
Why?
Models, Cardiovascular
1
1991
47
0.020
Why?
Family Health
1
1990
71
0.020
Why?
Molecular Weight
1
1990
119
0.020
Why?
Aorta
1
1991
124
0.020
Why?
In Vitro Techniques
1
1990
241
0.020
Why?
Iodine Radioisotopes
2
1979
36
0.020
Why?
Phosphorylation
1
1990
574
0.020
Why?
Mice, Inbred C57BL
2
2005
1561
0.020
Why?
Binding Sites
2
1979
352
0.020
Why?
Half-Life
1
1988
34
0.020
Why?
North America
1
2008
39
0.020
Why?
Dabigatran
1
2008
20
0.020
Why?
Ultrasonography
2
2000
240
0.020
Why?
Predictive Value of Tests
2
2000
474
0.020
Why?
Nephrotic Syndrome
1
1987
8
0.020
Why?
Blood Pressure Determination
1
2007
27
0.020
Why?
Blood Flow Velocity
1
2007
64
0.020
Why?
Elasticity
1
2007
51
0.020
Why?
Indicators and Reagents
1
2006
26
0.020
Why?
Regression Analysis
1
2007
210
0.020
Why?
Membrane Proteins
1
1990
483
0.020
Why?
Drug Monitoring
1
2006
36
0.020
Why?
Base Sequence
2
2001
582
0.020
Why?
Leukemia
1
1986
30
0.020
Why?
Complement C4b
1
1986
4
0.020
Why?
Disease Susceptibility
1
1986
74
0.020
Why?
Bandages
1
2005
14
0.020
Why?
Genes, bcl-2
1
2005
3
0.020
Why?
Mifepristone
1
2005
4
0.020
Why?
Hormone Antagonists
1
2005
6
0.010
Why?
Body Mass Index
1
2007
397
0.010
Why?
Whole Blood Coagulation Time
1
1984
6
0.010
Why?
Models, Biological
2
1984
466
0.010
Why?
Hemoglobins
1
2005
118
0.010
Why?
APACHE
1
2004
4
0.010
Why?
Endothelium
1
2004
28
0.010
Why?
Fibrin
1
2004
17
0.010
Why?
Therapeutic Equivalency
1
1984
4
0.010
Why?
Autonomic Nervous System Diseases
1
2004
5
0.010
Why?
Goats
1
1984
11
0.010
Why?
Hypertension
1
2007
308
0.010
Why?
History, 20th Century
1
1984
84
0.010
Why?
C-Reactive Protein
1
2004
92
0.010
Why?
Follow-Up Studies
2
1998
1011
0.010
Why?
Prodrugs
1
2003
30
0.010
Why?
Endothelial Protein C Receptor
1
2003
6
0.010
Why?
France
1
2003
15
0.010
Why?
Italy
1
2003
13
0.010
Why?
Mice, Transgenic
1
2005
507
0.010
Why?
Liver Cirrhosis
1
1984
72
0.010
Why?
Solubility
1
2003
73
0.010
Why?
Antigens, CD7
1
2002
1
0.010
Why?
Neprilysin
1
2002
2
0.010
Why?
Lymphocyte Subsets
1
2002
8
0.010
Why?
Dicumarol
1
1982
1
0.010
Why?
Thrombin Time
1
1982
2
0.010
Why?
Immunophenotyping
1
2002
60
0.010
Why?
Apolipoproteins B
2
1993
18
0.010
Why?
Cell Division
1
2002
154
0.010
Why?
Hematopoietic Stem Cells
1
2002
59
0.010
Why?
Severity of Illness Index
1
2004
450
0.010
Why?
Health Status Indicators
1
2002
25
0.010
Why?
Fetal Tissue Transplantation
1
2001
1
0.010
Why?
Organ Culture Techniques
1
2001
56
0.010
Why?
Gene Rearrangement, B-Lymphocyte, Heavy Chain
1
2001
3
0.010
Why?
Radiation Chimera
1
2001
5
0.010
Why?
Immunoglobulin Variable Region
1
2001
8
0.010
Why?
Specific Pathogen-Free Organisms
1
2001
13
0.010
Why?
CD5 Antigens
1
2001
12
0.010
Why?
Antigens, Differentiation, B-Lymphocyte
1
2001
12
0.010
Why?
Genes, Immunoglobulin
1
2001
10
0.010
Why?
Graft Survival
1
2001
28
0.010
Why?
Platelet Count
1
1982
111
0.010
Why?
DNA Primers
1
2001
146
0.010
Why?
Peripheral Vascular Diseases
1
2002
64
0.010
Why?
Lymphocyte Activation
1
2002
209
0.010
Why?
Prognosis
1
2004
802
0.010
Why?
Canada
1
2001
60
0.010
Why?
Bone Marrow
1
2001
76
0.010
Why?
Obesity
1
2007
667
0.010
Why?
Liver Transplantation
1
2001
56
0.010
Why?
Models, Animal
1
2001
129
0.010
Why?
Exercise Test
1
2002
248
0.010
Why?
Cell Cycle
1
2001
161
0.010
Why?
Odds Ratio
1
2001
236
0.010
Why?
Flow Cytometry
1
2001
287
0.010
Why?
Cellular Senescence
1
2001
125
0.010
Why?
Walking
1
2002
134
0.010
Why?
Survival Rate
1
2001
428
0.010
Why?
False Positive Reactions
1
2000
31
0.010
Why?
Outpatients
1
2000
44
0.010
Why?
Binding, Competitive
1
1979
62
0.010
Why?
False Negative Reactions
1
1979
24
0.010
Why?
Evaluation Studies as Topic
1
1979
43
0.010
Why?
Hip Joint
1
1979
19
0.010
Why?
Hip Fractures
1
1979
10
0.010
Why?
RNA, Messenger
1
2001
657
0.010
Why?
Inflammation
1
2004
629
0.010
Why?
Knee Joint
1
1979
43
0.010
Why?
Chemistry
1
1979
10
0.010
Why?
Gene Expression Profiling
1
2001
452
0.010
Why?
Chemical Phenomena
1
1979
22
0.010
Why?
Chromatography, Affinity
1
1979
32
0.010
Why?
Fibrinolysin
1
1979
16
0.010
Why?
Risk Assessment
1
2001
610
0.010
Why?
Ischemia
1
1999
83
0.010
Why?
Electrophoresis, Polyacrylamide Gel
1
1979
166
0.010
Why?
Thrombasthenia
1
1998
1
0.010
Why?
von Willebrand Diseases
1
1998
4
0.010
Why?
Clinical Protocols
1
1998
46
0.010
Why?
Arthritis, Rheumatoid
1
1979
134
0.010
Why?
Equipment Design
1
1998
217
0.010
Why?
Chromatography, Gel
1
1996
36
0.010
Why?
von Willebrand Factor
1
1996
36
0.010
Why?
Methods
1
1995
27
0.010
Why?
United States
1
2001
2139
0.010
Why?
Hematuria
1
1994
10
0.010
Why?
Thrombocytopenia
1
1996
113
0.010
Why?
Chemical Precipitation
1
1993
6
0.010
Why?
Cholesterol
1
1993
200
0.010
Why?
Genes, Recessive
1
1991
21
0.010
Why?
Genes, Dominant
1
1991
35
0.010
Why?
Blotting, Southern
1
1991
26
0.010
Why?
Polymorphism, Restriction Fragment Length
1
1991
26
0.010
Why?
Gene Amplification
1
1991
22
0.010
Why?
Chromosome Mapping
1
1991
130
0.010
Why?
Polymerase Chain Reaction
1
1991
268
0.010
Why?
Alleles
1
1991
350
0.010
Why?
Molecular Sequence Data
1
1991
1048
0.000
Why?
Child, Preschool
1
1991
1133
0.000
Why?
Lupus Erythematosus, Systemic
1
1995
990
0.000
Why?
Chromogenic Compounds
1
1986
2
0.000
Why?
Dipeptides
1
1986
22
0.000
Why?
Antigens
1
1986
67
0.000
Why?
Chronic Disease
1
1986
271
0.000
Why?
Surface Properties
1
1984
134
0.000
Why?
Comp's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (399)
Explore
_
Co-Authors (6)
Explore
_
Similar People (58)
Explore
_
Same Department Expand Description
Explore
_